Stephen J Mcandrew is Chief Business Officer of Sonnet BioTherapeutics Holdings, Inc.. Currently has a direct ownership of 0 shares of SONN, which is worth approximately $0. The most recent transaction as insider was on Dec 02, 2025, when has been sold 6,446 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
n/a 12M change
Total Value Held $0

STEPHEN J MCANDREW Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 02 2025
SELL
Sale (or disposition) back to the issuer
-
6,446 Reduced 100.0%
0 Common Stock
Jul 11 2025
BUY
Grant, award, or other acquisition
-
6,000 Added 48.21%
6,446 Common Stock
SJM

Stephen J Mcandrew

Chief Business Officer
Princeton,, NJ

Track Institutional and Insider Activities on SONN

Follow Sonnet BioTherapeutics Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SONN shares.

Notify only if

Insider Trading

Get notified when an Sonnet Bio Therapeutics Holdings, Inc. insider buys or sells SONN shares.

Notify only if

News

Receive news related to Sonnet BioTherapeutics Holdings, Inc.

Track Activities on SONN